Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Create Alert
Watchlist
Camlin Fine Sciences
₹145.39
+9.81 (7.24%)
1D
Manage alerts
Active alerts for Camlin Fine Sciences
ADD NEW ALERT
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Marketsmojo .
12 hours ago
Camlin Fine Sciences Ltd surged 8.7% on 22 Jan 2026, reaching Rs 145.8. The stock outperformed the Specialty Chemicals sector and market benchmarks after a 2-day decline.
BSE .
6 days ago
CFS Europe S.p.A., a subsidiary of Camlin Fine Sciences, filed for liquidation due to weak demand and high energy costs. The appeal was submitted to the Tribunal of Ravenna citing inability to pay debts or make recovery investments.
BSE .
2 weeks ago
Camlin Fine Sciences acquired 11,00,000 Vinpai shares via bond conversion, raising its stake to 83.82%. Vinpai, a French ingredient tech firm, specializes in algae-based solutions; its FY24 turnover was €9.2M.
BSE .
2 weeks ago
India Ratings downgraded Camlin Fine Sciences Ltd's long-term rating to IND BBB- Stable and short-term rating to IND A3 due to weak FY26 performance and high working capital needs. CFSL's vanillin business faces pricing headwinds from US tariffs, but blends business shows profitability. FY27 EBITDA improvement expected to aid debt repayments.
Business Standard .
2 weeks ago
InCred Equities reiterates Add call on Camlin Fine Sciences, citing benefits from tight vanillin markets in US and Europe. CFSL's blend portfolio and Vinpai acquisition expected to boost margins, create entry barriers, and unlock revenue potential.
ScoutQuest .
4 weeks ago
Camlin Fine Sciences acquires 78.7% in French firm Vinpai, plans tender offer for remaining shares at €3.6 each. Regulatory delays in India postpone offer filing to Feb 2026; stake rises to 83.8% post bond conversion.
Marketsmojo .
1 month ago
Camlin Fine Sciences surged 7.1%, hitting an intraday high of Rs 157.05. The stock outperformed Sensex, which rose 0.5% on 12 Dec 2025.
ScoutQuest .
2 months ago
Camlin Fine Sciences acquires majority stake in Vinpai at INR 247.7/share. Indian regulatory approval delayed to Nov 18, block acquisition by Nov 30.
Livesquawk .
2 months ago
Camlin Fine Sciences targets margin revival, growth in blends, aroma; Vanillin segment up 41% YoY. Focus on global market penetration, tariff-led margin recovery in H2 FY26; strong order book, acquisition-led growth.
BSE .
2 months ago
Camlin Fine Sciences held a call on Q2 FY25 results, audio available online. Management confirmed no UPSI shared; compliance under SEBI LODR regulations ensured.